A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep ...

Those results were released to the press yesterday in this announcement on the WCC website and, as expected from the ...

Viruses like the one that causes COVID-19 constantly mutate, rendering many antibody treatments ineffective. A Stanford-led ...

Monoclonal antibodies like etesevimab have lost efficacy against Omicron subvariants, necessitating innovative solutions.

The primary driver behind last 12 months revenue was the New Zealand segment contributing a total revenue of NZ$625.9m (42% ...

When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations ...

While it may not be enough for some shareholders, we think it is good to see the Restaurant Brands New Zealand ...

Findings reported by a team of virologists at the Center for Emerging Infectious Diseases at Wuhan Institute of Virology.

Among palm oil products, refined bleached deodorized (RBD) palmolein imports fell to 30,465 tonne from 2,44,678 tonne a year ago. Crude palm oil shipments declined to 2,40,276 tonne from 5,32,877 ...

It can bind with Spike-RBD and occupy the same site as the ACE2 receptor, thereby hindering viral entry into cells expressing ACE2. To explore the effect of different point mutations on the binding of ...